Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Signaling

Background:

• CD28 costimulation is vital for T cell activation, influencing gene transcription, mRNA stability, metabolism, and survival.
• The precise molecular pathways of CD28 signaling remain incompletely understood.
• The role of Ras/MAPK signaling in CD28 costimulation has been debated.

Purpose of the Study:

• To investigate the role of Ras signaling in CD28-mediated T cell costimulation.
• To determine if Ras signaling is sufficient to functionally replace CD28 costimulatory signals.
• To elucidate the molecular mechanisms by which CD28 enhances T cell responses.

Main Methods:

• Confocal microscopy to observe RasGEF relocalization.
• Biochemical analysis of T cell receptor (TCR)-induced Ras activation.
• Adenoviral transduction of constitutively active H-Ras (61L) in CD4(+) T cells.
• Assessment of downstream signaling (AKT, JNK, ERK phosphorylation) and functional outcomes (IL-2 secretion, anergy, glucose uptake, cell survival).

Main Results:

• CD28 costimulation induced Ras activation and RasGRP relocalization to the T cell-APC interface.
• Constitutively active Ras mimicked CD28's effects on IL-2 production, anergy prevention, glucose uptake, and cell survival.
• Active Ras enhanced IL-2 gene transcription and mRNA stability, similar to CD28.
• Active Ras induced IL-2 production via MEK-1 in response to ionomycin.

Conclusions:

• Ras signaling plays a central role in mediating the diverse functional outcomes of CD28 costimulation in T cells.
• Ras activation is sufficient to functionally replace key aspects of CD28-mediated T cell activation.
• These findings clarify the molecular underpinnings of T cell costimulation and identify Ras as a key signaling node.